| 1 |
David Meiri |
Emc Ip Holding Company |
215 |
| 2 |
Thomas Koletschka |
Berkshire Grey Operating Company |
173 |
| 3 |
Gene Temple Price |
Berkshire Grey Operating Company |
166 |
| #4 |
Alfredo C. Castro |
Infinity Pharmaceuticals |
113 |
| #5 |
Daniel Theobald |
Vecna Robotics |
91 |
| #6 |
Andrew J. Campanella |
Witricity |
83 |
| #7 |
Kenneth R. Crounse |
E Ink Holdings |
79 |
| #8 |
Guy M. Danner |
E Ink Holdings |
67 |
| #9 |
Kai Cao |
Alibaba |
66 |
| #10 |
Qing Tan |
Zoll Medical |
65 |
| #10 |
John M. Sheehan |
Microsoft |
65 |
| #12 |
Christopher A. Evans |
Microsoft |
58 |
| #13 |
James W. O'Toole, Jr. |
Cisco |
57 |
| #13 |
Bryan Lochman |
Panasonic |
57 |
| #15 |
Eli Cohen |
Aac Trade |
54 |
| #16 |
R. Rox Anderson |
The General Hospital |
49 |
| #16 |
Thomas O'Connor |
Idexx Laboratories |
49 |
| #18 |
Andre Lescarbeau |
Infinity Pharmaceuticals |
48 |
| #18 |
Marten Van Dijk |
Emc |
48 |
| #20 |
Upma Sharma |
Arsenal Medical |
47 |
| #21 |
Gary Palladino |
Sharkninja Operating |
44 |
| #21 |
Catherine A. Evans |
Infinity Pharmaceuticals |
44 |
| #23 |
Zhan Wang |
Verily Life Sciences |
42 |
| #23 |
James J. Dattolo |
Deka Products Limited Parternship |
42 |
| #23 |
David Cleary |
General Motors |
42 |
| #26 |
Gaston de los Reyes |
Spf Innovations |
41 |
| #27 |
Christopher Cacioppo |
Sanford |
40 |
| #28 |
Kamal Hadidi |
6K |
39 |
| #28 |
Zachary John Jackowski |
Boston Dynamics |
39 |
| #28 |
Ganesh Venkataraman |
MIT |
39 |
| #28 |
Christopher Luke Kaufman |
Zoll Medical |
39 |
| #32 |
Peter Mason |
Regeneron Pharmaceuticals |
38 |
| #33 |
Christopher M. Ward |
Broadcom |
37 |
| #33 |
Anuj Madan |
Skyworks Solutions |
37 |
| #33 |
Jochen Mueller |
Infineon Technologies Ag |
37 |
| #36 |
Frederic Durand |
MIT |
36 |
| #36 |
Mark Steven Schnittman |
Irobot |
36 |
| #38 |
Chad C. Huval |
Genzyme |
35 |
| #38 |
Thomas E. Devlin |
Lucky Litter |
35 |
| #38 |
Mark A. Morris |
Vertex Pharmaceuticals Incorporated |
35 |
| #41 |
Michael G. Moebius |
Draper Laboratory |
34 |
| #41 |
Holly G. Gates |
E Ink Holdings |
34 |
| #41 |
Daniel A. Snyder |
Infinity Pharmaceuticals |
34 |
| #41 |
Mihai Duduta |
24M Technologies |
34 |
| #41 |
Ginger Rakestraw |
Bristol-Myers Squibb |
34 |
| #41 |
Matthew Scot Rosen |
Hyperfine Research |
34 |
| #41 |
Robert W. Scheifler |
Oracle |
34 |
| #48 |
Michael Charles Hewitt |
Sunovion Pharmaceuticals |
33 |
| #49 |
William J. Bailey |
Schlumberger Technology |
32 |
| #49 |
Samuel Duffley |
Monotony.Ai |
32 |